Journal of Dental Anesthesia and Pain Medicine

  • 제21권1호
  • /
  • Pages.49-59
  • /
  • 2021
  • /
  • 2383-9309(pISSN)
  • /
  • 2383-9317(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지
DOI QR코드

DOI QR Code

Efficacy of phentolamine mesylate in reducing the duration of various local anesthetics

  • 투고 : 2020.10.23
  • 심사 : 2021.01.03
  • 발행 : 2021.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: To evaluate changes in the effectiveness of phentolamine mesylate in combination with different local anesthetics (LAs) and vasoconstrictors. A prospective randomized double-blind study was conducted with 90 patients divided into three groups, with each group being administered one of three different LAs: lidocaine 2% 1/80,000, articaine 4% 1/200,000, and bupivacaine 0.5% 1/200,000. Methods: We compared treatments administered to the mandible involving a LA blockade of the inferior alveolar nerve. Results were assessed by evaluating reduction in total duration of anesthesia, self-reported patient comfort using the visual analog pain scale, incidence rates of the most common adverse effects, overall patient satisfaction, and patient feedback. Results: The differences among the three groups were highly significant (P < 0.001); time under anesthesia was especially reduced for both the lip and tongue with bupivacaine. The following adverse effects were reported: pain at the site of the anesthetic injection (11.1%), headaches (6.7%), tachycardia (1.1%), and heavy bleeding after treatment (3.3%). The patients' feedback and satisfaction ratings were 100% and 98.9%, respectively. Conclusions: Efficient reversal of LAs is useful in dentistry as it allows patients to return to normal life more readily and avoid common self-injuries sometimes caused by anesthesia. Phentolamine mesylate reduced the duration of anesthesia in the three studied groups, with the highest reduction reported in the bupivacaine group (from 460 min to 230 min for the lip and 270 min for the tongue [P < 0.001]).

키워드

참고문헌

  1. Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog 2012; 59: 90-101. https://doi.org/10.2344/0003-3006-59.2.90
  2. Laviola M, McGavin SK, Freer GA, Plancich G, Woodbury SC, Marinkovich S, et al. Randomized study of phentolamine mesylate for reversal of local anesthesia. J Dent Res 2008; 87: 635-9. https://doi.org/10.1177/154405910808700717
  3. Nourbakhsh N, Shirani F, Babaei M. Effect of phentolamine mesylate on duration of soft tissue local anesthesia in children. J Res Pharm Pract 2012; 1: 55-9. https://doi.org/10.4103/2279-042x.108371
  4. Rutherford B, Zeller JR, Thake D. Local and systemic toxicity of intraoral submucosal injections of phentolamine mesylate (OraVerse). Anesth Prog 2009; 56: 123-7. https://doi.org/10.2344/0003-3006-56.4.123
  5. Grover HS, Gupta A, Saksena N, Saini N. Phentolamine mesylate: It's role as a reversal agent for unwarranted prolonged local analgesia. J Indian Soc Pedod Prev Dent 2015; 33: 265-8. https://doi.org/10.4103/0970-4388.165646
  6. Saunders TR, Psaltis G, Weston JF, Yanase RR, Rogy SS, Ghalie RG. In-practice evaluation of OraVerse for the reversal of soft-tissue anesthesia after dental procedures. Compend Contin Educ Dent 2011; 32: 58-62.
  7. Hersh EV, Lindemeyer R, Berg JH, Casamassimo PS, Chin J, Marberger A, et al. Phase Four, Randomized, Double-Blinded, Controlled Trial of Phentolamine Mesylate in Two- to Five-year-old Dental Patients. Pediatr Dent 2017; 15; 39: 39-45.
  8. Daublander M, Liebaug F, Niedeggen G, Theobald K, Kurzinger ML. Effectiveness and safety of phentolamine mesylate in routine dental care. J Am Dent Assoc 2017; 148: 149-56. https://doi.org/10.1016/j.adaj.2016.11.017
  9. Donaldson M, Goodchild JH. Pharmacological reversal agents in dental practice: keys to patient safety. Compend Contin Educ Dent 2016; 37: 681-7.
  10. Elmore S, Nusstein J, Drum M, Reader A, Beck M, Fowler S. Reversal of pulpal and soft tissue anesthesia by using phentolamine: a prospective randomized, single-blind study. J Endod 2013; 39: 429-34. https://doi.org/10.1016/j.joen.2012.12.024
  11. Boynes SG, Riley AE, Milbee S, Bastin MR, Price ME, Ladson A. Evaluating complications of local anesthesia administration and reversal with phentolamine mesylate in a portable pediatric dental clinic. Gen Dent 2013; 61: 70-6.
  12. Prasanna JS. OraVerse: reverses numbness after dental procedures. J Maxillofac Oral Surg 2012; 11: 212-9. https://doi.org/10.1007/s12663-011-0318-6
  13. Moore PA, Hersh EV, Papas AS, Goodson JM, Yagiela JA, Rutherford B. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog 2008; 55: 40-8. https://doi.org/10.2344/0003-3006(2008)55[40:POLWEF]2.0.CO;2
  14. Hersh EV, Moore PA, Saraghi M. Phentolamine mesylate: pharmacology, efficacy, and safety. Gen Dent 2019; 67: 12-7.
  15. Tavares M, Goodson JM, Studen-Pavlovich D, Yagiela JA, Navalta LA, Rogy S, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients. J Am Dent Assoc 2008; 139: 1095-104. https://doi.org/10.14219/jada.archive.2008.0312
  16. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91. https://doi.org/10.3758/BF03193146
  17. Calvo-Lobo C, Almazan-Polo J, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Palomo-Lopez P, Rodriguez-Sanz D, et al. Ultrasonography comparison of diaphragm thickness and excursion between athletes with and without lumbopelvic pain. Phys Ther Sport 2019; 37: 128-37. https://doi.org/10.1016/j.ptsp.2019.03.015
  18. Heft MW, Parker SR. An experimental basis for revising the graphic rating scale for pain. Pain 1984; 19: 153-61. https://doi.org/10.1016/0304-3959(84)90835-2
  19. Trullenque-Eriksson A, Guisado-Moya B. Comparative study of two local anesthetics in the surgical extraction of mandibular third molars: bupivacaine and articaine. Med Oral Patol Oral Cir Bucal 2011; 16: e390-6. https://doi.org/10.4317/medoral.16.e390
  20. Gregorio LV, Giglio FP, Sakai VT, Modena KC, Colombini BL, Calvo AM, et al. A comparison of the clinical anesthetic efficacy of 4% articaine and 0.5% bupivacaine (both with 1:200,000 epinephrine) for lower third molar removal. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 19-28. https://doi.org/10.1016/j.tripleo.2007.11.024
  21. Fernandez C, Reader A, Beck M, Nusstein J. A prospective, randomized, double-blind comparison of bupivacaine and lidocaine for inferior alveolar nerve blocks. J Endod 2005; 31: 499-503. https://doi.org/10.1097/01.don.0000167395.61075.38
  22. Michaud PL, Flood B, Brillant MS. Reversing the effects of 2% Lidocaine: A randomized controlled clinical trial. J Dent 2018; 72: 76-9. https://doi.org/10.1016/j.jdent.2018.03.009
  23. Hersh EV, Moore PA, Papas AS, Goodson JM, Navalta LA, Rogy S, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc 2008; 139: 1080-93 https://doi.org/10.14219/jada.archive.2008.0311
  24. Fowler S, Nusstein J, Drum M, Reader A, Beck M. Reversal of soft-tissue anesthesia in asymptomatic endodontic patients: a preliminary, prospective, randomized, single-blind study. J Endod 2011; 37: 1353-8. https://doi.org/10.1016/j.joen.2011.06.019
  25. Prados-Frutos JC, Rojo R, Gonzalez-Serrano J, Gonzalez-Serrano C, Sammartino G, Martinez-Gonzalez JM, et al. Phentolamine mesylate to reverse oral soft-tissue local anesthesia: A systematic review and meta-analysis. J Am Dent Assoc 2015; 146: 751-9 https://doi.org/10.1016/j.adaj.2015.04.018
  26. Michaud PL, Nowe E, Smith Brillant M. Reversing the effects of 0.5% bupivacaine using phentolamine mesylate: a preliminary randomized controlled clinical trial. J Clin Pharmacol 2020.
  27. Kriangcherdsak Y, Raucharernporn S, Chaiyasamut T, Wongsirichat N. Success rates of the first inferior alveolar nerve block administered by dental practitioners. J Dent Anesth Pain Med 2016; 16: 111-6. https://doi.org/10.17245/jdapm.2016.16.2.111
  28. Sawadogo A, Coulibaly M, Quilodran C, Bationo R, Konsem T, Ella B. Success rate of first attempt 4% articaine para-apical anesthesia for the extraction of mandibular wisdom teeth. J Stomatol Oral Maxillofac Surg 2018; 119: 486-8. https://doi.org/10.1016/j.jormas.2018.06.005
  29. Alhindi M, Rashed B, AlOtaibi N. Failure rate of inferior alveolar nerve block among dental students and interns. Saudi Med J 2016; 37: 84-9. https://doi.org/10.15537/smj.2016.1.13278
  30. Gazal G. Overcoming the failure of anesthesia in the mandibular teeth. Saudi Med J 2019; 40: 425. https://doi.org/10.15537/smj.2019.5.24078
  31. Vinnakota DN, Kamatham R. Safety profile of phentolamine mesylate as reversal agent of pulpal and soft tissue dental anesthesia: a systematic review and meta-analysis. Quintessence Int 2019; 50: 568-75.
  32. Helmi M, AlDosari M, Tavares M. Phentolamine mesylate may be a safe and effective option to reduce discomfort and time to recovery after dental care with local anesthesia. J Evid Based Dent Pract 2018; 18: 181-4. https://doi.org/10.1016/j.jebdp.2018.02.005
  33. Froum SJ, Froum SH, Malamed SF. The use of phentolamine mesylate to evaluate mandibular nerve damage following implant placement. Compend Contin Educ Dent 2010; 31: 520, 522-8.
  34. Shetty C, Devanathan N, Shetty A, Shetty S, Hegde MN. Phentolamine mesylate as a drug for reversal of local anaesthesia --a questionnaire based study. J Evol Med Dent Sci 2020; 43: 3227-30.
  35. Yagiela JA. What's new with phentolamine mesylate: a reversal agent for local anaesthesia? SAAD Dig 2011; 27: 3-7.
  36. Malamed SF. Modern dental pain control. Dent Today 2008; 27: 72, 74, 76-7.
  37. Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth 2010; 57: 368-80. https://doi.org/10.1007/s12630-010-9275-7
  38. Butterworth JF 4th. Models and mechanisms of local anesthetic cardiac toxicity: a review. Reg Anesth Pain Med 2010; 35: 167-76. https://doi.org/10.1097/AAP.0b013e3181d231b9
  39. Gonca E, Catli D. The effects of lidocaine with epinephrine on bupivacaine-induced cardiotoxicity. Turk J Anaesthesiol Reanim 2018; 46: 447-52. https://doi.org/10.5152/TJAR.2018.64624
  40. Powell MF, Jarzombek KW, Venhuizen KJ, Tubinis MD, Morgan CJ, Frolich MA. Comparing bupivacaine, lidocaine, and a combination of bupivacaine and lidocaine for labor epidural activation: a prospective, randomized, double-blind study. Asian J Anesthesiol 2019; 57: 55-60.

피인용 문헌

  1. Use of Phentolamine Mesylate in Implant Surgery: Analysis of Adverse Effects and Haemodynamic Changes vol.10, pp.17, 2021, https://doi.org/10.3390/jcm10173875